News

Inceptua, a global pharmaceutical company and service partner and Portola – US developer and manufacturer of therapeutic agents focusing on thrombosis and other haematological conditions – have entered into an agreement whereby Inceptua will become Portola’s exclusive distribution partner...

Regeneron  announced an expanded agreement with the U.S. Department of Health and Human Services (HHS) to develop new treatments combating the novel coronavirus, 2019-nCoV, which was recently declared a global public health emergency by the World Health Organization. Regeneron has...

AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced that it has reached its patient enrollment target in the company's phase 2 clinical trial for glioblastoma. The trial has achieved its enrollment target ahead of...

The Sanofi phase 2b study evaluating its investigational BTK (Brutons tyrosine kinase) inhibitor (SAR442168), an oral, brain-penetrant, selective small molecule, achieved its primary endpoint. In the trial, SAR442168 significantly reduced disease activity associated with multiple sclerosis (MS) as measured by...

Teva Pharmaceutical Industries Ltd announced positive results from two Phase 2/3 trials evaluating AJOVY® (fremanezumab) in patients in Japan. AJOVY is under development in Japan by Otsuka Pharmaceutical Co., Ltd. (Otsuka) as part of a May 2017 exclusive license...

International Pharmaceutical Expo (INTERPHEX), the premier event dedicated to pharmaceutical, biotechnology and device innovation, technology and knowledge from development through commercialization, and the Parenteral Drug Association (PDA), the leading industry provider of science, technology and regulatory information, annually attracts...

Over 10% of the Irish public do not clean their face at all, while almost a third only use soap and water, new research suggests. In a survey conducted by McCabes Pharmacy, a fifth of respondents said they only wash...